Oruka Therapeutics (ORKA) Enterprise Value (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.87% |
| Dec 31, 2025 | -121.25% |
| Sep 30, 2025 | -5.63% |
| Jun 30, 2025 | 48.23% |
| Mar 31, 2025 | -68.87% |
| Dec 31, 2024 | 6.86% |
| Sep 30, 2024 | -1,111.80% |
| Jun 30, 2024 | 7.30% |
| Mar 31, 2024 | 4.08% |
| Dec 31, 2023 | 2.74% |
| Sep 30, 2023 | 4.16% |
| Jun 30, 2023 | 1.70% |
| Mar 31, 2023 | 3.76% |
| Dec 31, 2022 | 3.40% |
| Sep 30, 2022 | 5.38% |
| Jun 30, 2022 | 5.34% |
| Mar 31, 2022 | 8.06% |
| Dec 31, 2021 | 8.50% |
| Sep 30, 2021 | 7.73% |
| Jun 30, 2021 | 5.58% |
| Mar 31, 2021 | -36.40% |
| Dec 31, 2020 | 3.96% |
| Sep 30, 2020 | -362.78% |
| Jun 30, 2020 | -65.43% |
| Mar 31, 2020 | 20.20% |
| Dec 31, 2019 | 13.29% |
| Sep 30, 2019 | 3.22% |
| Jun 30, 2019 | -24.48% |
| Mar 31, 2019 | -21.16% |
| Dec 31, 2018 | 18.20% |
| Sep 30, 2018 | 16.16% |
| Jun 30, 2018 | 20.35% |
| Mar 31, 2018 | -2.93% |
| Dec 31, 2017 | 26.32% |
| Sep 30, 2017 | 0.35% |
| Jun 30, 2017 | 16.68% |
| Mar 31, 2017 | 9.22% |
| Dec 31, 2016 | 9.82% |
| Sep 30, 2016 | 10.96% |
| Jun 30, 2016 | 13.94% |
| Mar 31, 2016 | 21.07% |
| Dec 31, 2015 | 6.46% |
| Sep 30, 2015 | 5.91% |
| Jun 30, 2015 | -261.84% |
| Mar 31, 2015 | 20.65% |
| Dec 31, 2014 | 10.99% |
| Sep 30, 2014 | 10.98% |
| Jun 30, 2014 | 8.61% |
| Mar 31, 2014 | -26.53% |
| Dec 31, 2013 | 10.07% |
| Sep 30, 2013 | 8.55% |
| Jun 30, 2013 | -476.02% |
| Mar 31, 2013 | -21.13% |
| Dec 31, 2012 | 5.23% |
| Sep 30, 2012 | 3.17% |
| Jun 30, 2012 | 24.72% |
| Mar 31, 2012 | 28.87% |
| Dec 31, 2011 | -3.39% |
| Sep 30, 2011 | 22.98% |
| Jun 30, 2011 | -46.76% |
| Mar 31, 2011 | 27.62% |
| Dec 31, 2010 | 11.14% |
| Sep 30, 2010 | 20.28% |